Surveillance of adverse events following immunization with combined attenuated live measles, mumps and rubella vaccines in Huzhou City from 2015 to 2021
ZHANG Chao, SHEN Jianyong, LUO Xiaofu, XU Qin'er, HAN Liping
Department of Immunization Planning, Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang 313000, China
Abstract:Objective To monitor the adverse events following immunization (AEFI) with combined attenuated live measles, mumps and rubella vaccines (MMR) in Huzhou City from 2015 to 2021, so as to provide insights into the implementation of the MMR immunization strategy. Methods All AEFI caused by MMR immunization in Huzhou City from 2015 to 2021 were captured from the AEFI Monitoring Information Management System of the Immunization Planning System of Chinese Disease Control and Prevention Information System, and the incidence, clinical features and epidemiological features of AEFI were analyzed descriptively. Results The reported incidence of AEFI caused by MMR immunization appeared a tendency towards a rise in Huzhou City from 2015 to 2021 (χ2trend=124.126, P<0.001). Totally 324 386 doses of MMR vaccines were immunized, and 317 cases with AEFI were reported, with an reported incidence rate of 9.77/104 doses. Following two-dose immunization, the reported incidence of AEFI caused by two-dose MMR immunization was significantly lower than by one-dose immunization (6.01/104 doses vs. 25.43/104 doses; χ2=113.692, P<0.001). The incidence rates of general reactions, abnormal reactions and coincidental events were 6.20/104 doses, 3.42/104 dose and 0.15/104 doses, respectively. Fever and allergic rash were predominant clinical manifestations of AEFI, and no vaccine quality accident, inoculation accident or psychogenic reaction were reported. There were 246 (77.60%) cases with AEFI within 24 hours following vaccination, and among children with AEFI, there were 173 boys (54.57%), and 200 children (63.09%) age ages of less than one year (63.09%). AEFI was reported in each quarter, and 99 cases (31.23%) were reported in the fourth quarter. The largest number of children with AEFI was reported in Wuxing District (78 cases, 24.61%). Conclusions The safety of MMR vaccination is high in Huzhou City. General reaction is the predominant AEFI, which mainly occurs within 24 hours following vaccination. Two-dose MMR vaccination does not increase the risk of AEFI.
张超, 沈建勇, 罗小福, 徐秦儿, 韩利萍. 2015—2021年湖州市MMR疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(1): 74-77.
ZHANG Chao, SHEN Jianyong, LUO Xiaofu, XU Qin'er, HAN Liping. Surveillance of adverse events following immunization with combined attenuated live measles, mumps and rubella vaccines in Huzhou City from 2015 to 2021. Preventive Medicine, 2023, 35(1): 74-77.
[1] 许青,熊萍,房学强,等.山东省两剂含腮腺炎成分疫苗纳入免疫规划后流行性腮腺炎短期预防效果评价[J].中华预防医学杂志,2018,52(3):265-270. [2] 王三凤,杨凯朝,史鲁斌,等.河南省2016—2018年含麻疹和风疹成分联合疫苗疑似预防接种异常反应监测[J].中国疫苗和免疫,2020,26(3):329-331,335. [3] 杜哲群,胡洁,沈国初,等.嘉兴市8月龄儿童接种MMR、MR疫苗疑似预防接种异常反应监测结果[J].预防医学,2020,32(11):1086-1090. [4] 罗小福,张超,沈建勇,等.湖州市流行性腮腺炎的流行病学特征(2004—2020年)[J].国际流行病学传染病学杂志,2022,49(2):125-128. [5] 中国政府网.关于印发《全国疑似预防接种异常反应监测方案》的通知[EB/OL].(2010-06-14)[2022-10-19].http://www.nhc.gov.cn/jkj/s3581/201402/5dd5633d93174a7c8e93d8af7579a613.shtml?from=timeline. [6] 张丽娜,李克莉,李燕,等.2020年中国疑似预防接种异常反应监测[J].中国疫苗和免疫,2022,28(2):208-218. [7] PAN X J,LV H K,CHEN F X,et al.Analysis of adverse events following immunization in Zhejiang,China,2019:a retrospective crosssectional study based on the passive surveillance system[J].Hum Vaccin Immunother,2021,17,(10):3823-3830. [8] 王晓柳,汤元妃.2018—2021年武义县疑似预防接种异常反应监测结果[J].预防医学,2022,34(11):1167-1171. [9] 何寒青,严睿,马燕丽,等.4岁儿童麻疹-流行性腮腺炎-风疹联合减毒活疫苗加强免疫的安全性和免疫原性观察[J].中华微生物学和免疫学杂志,2018,38(1):62-66. [10] 肖艳慧,常少英,白霜,等.4~6岁儿童接种麻疹-流行性腮腺炎-风疹联合减毒活疫苗加强免疫的免疫原性与安全性研究[J].中华流行病学杂志,2021,42(6):1086-1091. [11] 蒋薇薇,崔光辉,李岩岩,等.蜀山区儿童疑似预防接种异常反应监测分析[J].预防医学,2018,30(8):789-793. [12] 王晶晶,周杰,汤喜红,等.2017—2018年上海市金山区疑似预防接种异常反应监测分析[J].公共卫生与预防医学,2019,30(4):99-102.